Pipeline

Internal Programs

Immuno-oncology
APX201
Immuno-oncology
Undisclosed
Immuno-oncology

Partner Programs

Brolucizumab
Ocular Disease
ESBA1622
Ocular Disease
APX003/BD0801
Oncology
APX001/SSS07
Inflammation
APX003/TK001
Ocular Disease
TRK-950
Oncology
APX002/TK002
Inflammation
APX004/DYW101
Oncology